Antiviral activity against HIV1 bearing VSV envelope infected in human HeLa CD4 cells coexpressing LTR/beta-Gal gene assessed as reduction in virus-induced beta-galactosidase reporter gene activity after 72 hrs by single-cycle infection assay
Antiviral activity against HIV1 bearing HIV1 NL4-3 envelope infected in human HeLa CD4 cells coexpressing LTR/beta-Gal gene assessed as reduction in virus-induced beta-galactosidase reporter gene activity after 72 hrs by single-cycle infection assay
Antiviral activity against HIV1 bearing HIV1 NL4-3 envelope assessed as reduction in viral envelope-mediated membrane fusion by cell-based fusion assay
Antiviral activity against HIV1 bearing HIV1 NL4-3 envelope infected in human MT2 cells assessed as inhibition of HIV-envelope packed virions at 15 uM after 72 hrs by virus production assay relative to control
Antiviral activity against HIV1 bearing VSV envelope infected in human MT2 cells assessed as inhibition of VSV-envelope packed virions at 15 uM after 72 hrs by virus production assay relative to control